Expect Fewer Inhaled Steroids to Be Used in Chronic COPD Patients

You'll use more bronchodilators and fewer inhaled corticosteroids for chronic COPD...due to new GOLD guidelines.

Many COPD patients get an inhaled steroid/long-acting beta-agonist combo (Advair, Breo, Symbicort) for persistent symptoms.

But combining two long-acting bronchodilators (Anoro, etc) prevents more exacerbations...and has a lower pneumonia risk than steroid combos.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals